- 1. E7(86-93) Lipopeptide
- [A synthetic peptide (sequence: TLGIVCPI) vaccine consisting of amino acids 86 through 93 of the viral oncoprotein human papillomavirus (HPV) 16 E7. Vaccination with HPV-16 E7:86-93 peptide, which binds to HLA-A* 0201 molecule, may stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells positive for HPV-16 E7. ( NCI )] (UMLS (NCI) C0879333) HPV 16 E7:86-93 Peptide Vaccine;
HPV 16E7 86-93 Lipopeptide Vaccine;
HPV-16E7 (86-93) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 11. ELISA
- [immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase; while either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye; many variations of the method have been developed. ( CSP )] (UMLS (HL7) C0014441) =Laboratory Procedure =immunologic assay;
ObservationMethod |
- 2. E7(86-93) Lipopeptide/HPV-16 E7(12-20) Peptide Vaccine/Montanide ISA-51
- (UMLS (NCI) C0879335) =Therapeutic or Preventive Procedure
| - 12. ELISA, antigen capture
- [ELISA, antigen capture ( HL7V3.0 )] (UMLS (HL7) C1553127) =Laboratory Procedure =ObservationMethod;
|
- 3. E74-Like Factor 3
- [ESX, a novel member of the ETS transcription factor family, is a tumor marker exclusively expressed in epithelial cells. ESX contains two putative DNA-binding domains: an ETS domain and an A/T hook domain. (NCI) ( NCI )] (UMLS (NCI) C1308058) E74-Like Factor 3 ETS Domain Transcription Factor;
E74-Like Factor 3 ETS Domain Transcription Factor, Epithelial-Specific;
E74-Like Factor 3 ETS Domain Transcription Factor, Serine Box, Epithelial-Specific;
ELF3;
ELF3 Protein;
Epithelium-Specific ETS Factor 1;
ESE1;
ESX Protein;
ETS Domain Transcription Factor, Epithelial-Specific;
ETS Domain Transcription Factor, Serine Box;
ETS Domain Transcription Factor, Serine Box Epithelial-Specific =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 13. ELISA, avidin biotin peroxidase complex
- [ELISA, avidin biotin peroxidase complex ( HL7V3.0 )] (UMLS (HL7) C0201697) =Laboratory Procedure =ObservationMethod;
|
- 4. E74-Like Factor 3 (ETS Domain Transcription Factor, Epithelial-Specific) Gene
- [This gene is involved in the regulation of both transcription and epithelial cell differentiation. It also plays a role in angiogenesis. ( NCI )] (UMLS (NCI) C1366763) ELF3;
ELF3 Gene =Gene or Genome ;
| - 14. ELISA, peroxidase-antiperoxidase
- [ELISA, peroxidase-antiperoxidase ( HL7V3.0 )] (UMLS (HL7) C0201698) =Laboratory Procedure =ObservationMethod;
|
- 5. Eligibility
- [The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures. ( NCI )] (UMLS (NCI) C0013893) =Health Care Activity
| - 15. ELISPOT
- [ ] (UMLS (CSP) C0920508) enzyme linked immunospot assay =Laboratory Procedure
|
- 6. Eligibility Source
- (UMLS (HL7) C1550418) =Classification =HL7 Vocabulary Version 2.5;
=Insurance Company;
Employer;
Insured presented policy;
Insured presented card;
Signed statement on file;
Verbal information;
None | - 16. ELISPOT (enzyme linked immunospot assay)
- [ ] (UMLS (CSP) C0677645) =Laboratory Procedure ;
|
- 7. EligibilityActReasonCode
- [Identifies the reason or rational for why a person is eligibile for benefits under an insurance policy or progam. Examples: A person is a claimant under an automobile insurance policy are client deceased & adopted client has been given a new policy identifier. A new employee is eligible for health insurance as an employment benefit. A person meets a government program eligibility criteria for financial, age or health status. ( HL7V3.0 )] (UMLS (HL7) C1699570) =Idea or Concept ;
=ActReason;
=CoverageEligibilityReason | - 17. Eliten
- [The sodium salt of fosinopril, a phosphinic acid-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Fosinopril sodium is an ester prodrug that is hydrolysed by esterases to its active metabolite fosinoprilat. Fosinoprilat specifically and competitively inhibits angiotensin-converting enzyme thereby decreasing the formation of the potent vasoconstrictor angiotensin II, resulting in diminished vasopressor activity. In addition, angiotensin II-mediated aldosterone secretion by adrenal cortex is decreased, which results in a decrease of sodium retention and an increase of serum potassium. (NCI05) ( NCI )] (UMLS (NCI) C0733440) FOSINOPRIL SODIUM;
FOSINOPRIL SODIUM PREPARATION;
L-proline, 4-Cyclohexyl-1-[[[2-methyl-1-(1-oxopropoxy) propoxyl](4-phenylbutyl) phosphinyl]acetyl]-,Sodium Salt, trans- =Organophosphorus Compound; Pharmacologic Substance =FOSINOPRIL;
=FOSINOPRIL SODIUM 10 MG;
FOSINOPRIL SODIUM 20 MG;
FOSINOPRIL SODIUM 40 MG |
- 8. Eligible
- [Insurance coverage is in effect for healthcare service(s) and/or product(s). ( HL7V3.0 )] (UMLS (HL7) C1548635) =Idea or Concept =Certification status;
ActCoverageEligibilityConfirmationCode | - 18. ELIXIR
- [A clear, pleasantly flavored, sweetened hydroalcoholic liquid containing dissolved medicinal agents; it is intended for oral use. (NCI) ( NCI )] (UMLS (NCI) C0678430) =Biomedical or Dental Material =Oral Solution;
|
- 9. Eliminated
- [Taken out of, separated from, or eliminated. ( NCI )] (UMLS (NCI) C0849355) Out;
Removed;
Taken Out =Qualitative Concept | - 19. Elixophyllin
- (UMLS (NCI) C0700831) =Organic Chemical; Pharmacologic Substance
|
- 10. Elipten
- (UMLS (NCI) C0701949) =Organic Chemical; Pharmacologic Substance
| |
home
